The results of EMPA-REG OUTCOME Trial assess the role of empagliflozin in patients with type 2 diabetes and atherosclerotic cardiovascular disease.

The lack of studies for children and adolescents with type 2 diabetes has led to an absence of approval of new drugs for this patient population. This study reports findings of Liraglutide for youth.

Why having a high bone mineral density may not always decrease the risk of fractures. 

The company and FDA say certain pumps are vulnerable to hacking

Prevalence of high caregiver burden increased after initiation of dialysis

Increasing magnitude of stress myocardial perfusion abnormality tied to cardiac death risk in diabetes

Event rates did not differ for atrial fibrillation, myocardial infarction, congestive heart failure, stroke

Osteoporosis in intertrochanter more likely in women with high urinary triclosan concentration

Risk down particularly when linoleic acids replace saturated fats, trans fats, or carbohydrates

This is the last week that Emma Kammerer, L|E|C|O|M Bradenton School of Pharmacy, PharmD Candidate will be with us on her rotation. One of the topics we discussed was how to preserve beta cell function by starting aggressive management from day one. Like many pharmacists she was somewhat surprised by …